New program applies principles of DM to transplant patients.
One of the most common and costly complications related to transplant patients is organ rejection due to patient non-compliance. It's a huge issue because of the complicated medication regimens transplant patients must learn to deal with, and the numerous side-effects involved. For this reason, Aetna decided to offer transplant patients extra support in the form of a DM program that focuses on medication management, and early indications are the approach is having a positive effect.
D019090:Case Management; D019468:Disease Management; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008329:Managed Care Programs; D008910:Minnesota; D009723:Nurse-Patient Relations; D016377:Organ Transplantation / Q000451:nursing*; D010349:Patient Compliance / Q000706:statistics & numerical data*; D016730:Program Development; D014181:Transplantation Immunology / Q000187:drug effects
D007166:Immunosuppressive Agents